Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

NCT01427712 is registered in ClinicalTrials.gov with Mylan Inc. as lead sponsor.

NCT NCT01427712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01427712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Lead sponsor
Mylan Inc.
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
March 31, 2018
Enrollment
24 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, digestive system diseases, exocrine pancreatic insufficiency, pancreatic diseases